OTC Markets OTCQX - Delayed Quote USD
Medicenna Therapeutics Corp. (MDNAF)
0.7590
-0.0060
(-0.78%)
At close: April 23 at 2:19:39 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-16,341
-16,260
-12,657
-23,584
-15,311
Investing Cash Flow
--
--
--
10,050
5,013
Financing Cash Flow
23,511
--
24,760
3,878
18,256
End Cash Position
28,895
16,982
33,596
20,535
30,375
Issuance of Capital Stock
19,714
--
24,760
3,509
11,411
Repayment of Debt
--
--
--
-37
-39
Free Cash Flow
-16,374
-16,260
-12,657
-23,584
-15,311
3/31/2021 - 11/13/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NGENF NervGen Pharma Corp.
2.1300
-0.93%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
EPRX Eupraxia Pharmaceuticals Inc.
3.8400
-0.26%
NYMXF Nymox Pharmaceutical Corporation
0.1178
0.00%
TRVI Trevi Therapeutics, Inc.
6.27
+3.29%
PDSB PDS Biotechnology Corporation
1.2300
+6.96%
LRMR Larimar Therapeutics, Inc.
2.2600
-5.04%
MREO Mereo BioPharma Group plc
2.5600
+2.40%
XFOR X4 Pharmaceuticals, Inc.
0.2013
-0.84%
NAMSW NewAmsterdam Pharma Company N.V.
8.38
+4.75%